If you'd like to claim this company profile for BlueWhale Bio, please
Contact Us.
BlueWhale Bio: Partnerships and Licensing
Partnership and licensing opportunities from BlueWhale Bio.
Partnership Title: Faster, Simpler Immune Cell Manufacturing with Synecta™ Activators
Partnership Description ...
BlueWhale Bio's Synecta™ CDNPs mimic antigen-presenting cells, the body's native, potent T-cell activators, delivering Signals 1–3 ex vivo. They display TCR-stimulating and co-stimulatory ligands together with membrane-bound cytokines on a membrane enriched with adhesion molecules to enhance CDNP–T-cell interactions. Synecta™ CDNPs are compatible with viral and non-viral delivery systems, giving therapy developers flexibility in manufacturing.
Partnership Types ...
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partnership Category Areas ...
- Biopharmaceuticals
- Biopharmaceuticals-Technology
- Biopharmaceuticals-Discovery Platforms
- Biopharmaceuticals-Development Platforms
Claim This Profile
This is the Partnership and Licensing section of the company profile page for
BlueWhale Bio on the
Pharmaceutical Services
Directory. Companies listed on the directory can update their business information free of charge. If
this is your company and you'd like to claim this profile, please
Contact Us.
BlueWhale Bio company details, activities,
contacts and reviews.
BlueWhale Bio documents, images and videos.
BlueWhale Bio partnership and licensing
opportunities.
BlueWhale Bio latest news, announcements and
press releases.
BlueWhale Bio global factories, offices and
locations.
BlueWhale Bio legal and financial information.
BlueWhale Bio blogs, articles and journal
posts.
